IGF2BP3 Monoclonal Antibody (C2-E4), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA532838-Each-of-1 | In Stock | ₹ 46,413.50 |
PIMA532838 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,413.50
GST (18%): ₹ 8,354.43
Total Price: ₹ 54,767.93
Antigen
IGF2BP3
Classification
Monoclonal
Concentration
2 mg/mL
Formulation
PBS with 0.2% BSA, 50% Glycerol and 0.05% sodium azide, pH 7.4
Gene Accession No.
O00425, Q9CPN8
Gene Symbols
IGF2BP3
Immunogen
Recombinant protein within Human IMP-3 aa 352-579
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG1
Applications
Flow Cytometry, Immunocytochemistry, Immunohistochemistry, Western Blot, Western Blot
Clone
C2-E4
Conjugate
Unconjugated
Gene
IGF2BP3
Gene Alias
2610101N11Rik, AA522010, Ab2-255, AL022933, AU045931, cancer/testis antigen 98, CT98, hKOC, IGF2 mRNA-binding protein 3, IGF2BP3, IGF-II mRNA-binding protein 3, IMP3, IMP-3, insulin like growth factor 2 mRNA binding protein 3, insulin-l, insulin-like growth factor 2 mRNA binding protein 3, insulin-like growth factor 2 mRNA-binding protein 3, insulin-like growth factor 2, binding protein 3, KH domain containing protein overexpressed in cancer, KH domain-containing protein overexpressed in cancer, KOC, KOC1, Koc13, mimp3, mIMP-3, Neilsen, RGD1306512, VICKZ family member 3, Vickz3
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
10643, 140488, 312320
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- Mouse Monoclonal Antibody Insulin-like growth factor-II messenger RNA (mRNA)-binding protein-3 (IMP-3), also known as K homology domain-containing protein overexpressed in cancer (KOC) and L523S, is a member of the insulin-like growth factor-II mRNA-binding protein family and is expressed during embryogenesis and in some malignancies
- IMP-3 is expressed in malignant melanoma but not in benign nevi, even when dysplastic features are present; IMP-3 is expressed in a significantly higher proportion of melanomas than Spitz nevi; and IMP-3 is expressed in metastatic melanomas significantly more than in thin melanomas
- IMP-3 appears to be involved in the progression of malignant melanoma and may play an important role in the regulation of the biologic behavior of this tumor.